Back
Bright Minds Biosciences, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
DRUG.CX
Bright Minds Biosciences, Inc.
Last Price:
$118.29
Seasonality Move:
-25.59%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and DRUG.CX is experiencing slight buying pressure.
Bright Minds Biosciences, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 118.94 | Sell |
| 20-day SMA: | 108.09 | Buy |
| 50-day SMA: | 92.95 | Buy |
| 200-day SMA: | 60.31 | Buy |
| 8-day EMA: | 115.87 | Sell |
| 20-day EMA: | 108.71 | Buy |
| 50-day EMA: | 95.21 | Buy |
| 200-day EMA: | 67.11 | Buy |
Bright Minds Biosciences, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.5 | Buy |
| Relative Strength Index (14 RSI): | 57.07 | Buy |
| Chaikin Money Flow: | 34 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.04 - 117.82) | Buy |
| Bollinger Bands (100): | (58.19 - 98.05) | Buy |
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Bright Minds Biosciences, Inc. Stock
Is Bright Minds Biosciences, Inc. Stock a Buy?
-
Bright Minds Biosciences, Inc. share price is 114.23 while DRUG.CX 8-day simple moving average is 118.94, which is a Sell signal.
-
The stock price of DRUG.CX is 114.23 while Bright Minds Biosciences, Inc. 20-day SMA is 108.09, which makes it a Buy.
-
Bright Minds Biosciences, Inc. 50-day simple moving average is 92.95 while DRUG.CX share price is 114.23, making it a Buy technically.
-
DRUG.CX stock price is 114.23 and Bright Minds Biosciences, Inc. 200-day simple moving average is 60.31, creating a Buy signal.
DRUG.CX Technical Analysis vs Fundamental Analysis
Buy
63
Bright Minds Biosciences, Inc. (DRUG.CX)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy or a Sell?
-
Bright Minds Biosciences, Inc. stock is rated a BuyThe current Bright Minds Biosciences, Inc. [DRUG.CX] share price is $114.23. The Score for DRUG.CX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Bright Minds Biosciences, Inc. Stock Info
Market Cap:
809.7M
Price in USD:
114.23
Share Volume:
6.1K
Bright Minds Biosciences, Inc. 52-Week Range
52-Week High:
131.88
52-Week Low:
33.01
Buy
63
Bright Minds Biosciences, Inc. (DRUG.CX)
is a Buy
Bright Minds Biosciences, Inc. Share Price Forecast
-
What is the Bright Minds Biosciences, Inc. stock price today?The Bright Minds Biosciences, Inc. stock price is 114.23 USD today.
-
Will DRUG.CX stock go up or go down?Bright Minds Biosciences, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Bright Minds Biosciences, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bright Minds Biosciences, Inc. is not overvalued.
Is Bright Minds Biosciences, Inc. Stock a Buy?
-
Bright Minds Biosciences, Inc. share price is 114.23 while DRUG.CX 8-day exponential moving average is 115.87, which is a Sell signal.
-
The stock price of DRUG.CX is 114.23 while Bright Minds Biosciences, Inc. 20-day EMA is 108.71, which makes it a Buy.
-
Bright Minds Biosciences, Inc. 50-day exponential moving average is 95.21 while DRUG.CX share price is 114.23, making it a Buy technically.
-
DRUG.CX stock price is 114.23 and Bright Minds Biosciences, Inc. 200-day simple moving average is 67.11, creating a Buy signal.
Fundamental Analysis of Bright Minds Biosciences, Inc.
Is Bright Minds Biosciences, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.20 per share, and a decrease next year of $4.60 per share.
Technical Analysis of Bright Minds Biosciences, Inc.
Should I short Bright Minds Biosciences, Inc. stock?
-
DRUG.CX Moving Average Covergence Divergence (MACD) indicator is 8.5, suggesting Bright Minds Biosciences, Inc. is a Buy
-
Bright Minds Biosciences, Inc. Relative Strength Index (RSI) is 57.07, which suggest Bright Minds Biosciences, Inc. is overbought
-
The Bollinger Bands (25) for Bright Minds Biosciences, Inc. is (88.04 - 117.82), which suggest Bright Minds Biosciences, Inc. is a Buy
-
The Bollinger Bands (100) for Bright Minds Biosciences, Inc. is (58.19 - 98.05), which suggest Bright Minds Biosciences, Inc. is a Buy
* Bright Minds Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.